or Try an Advanced Search...

    Technical Analysis for MNMD - Mind Medicine (MindMed) Inc.

    Grade Last Price % Change Price Change
    D 8.22 0.00% 0.00
    MNMD closed down 4.97 percent on Friday, May 17, 2024, on 50 percent of normal volume.
    Earnings due: Jun 10
    *** please verify all earnings dates ***
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical MNMD trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    Fell Below 20 DMA Bearish -4.97%
    180 Bearish Setup Bearish Swing Setup -4.97%
    Bollinger Band Squeeze Range Contraction -4.97%
    NR7 Range Contraction -4.97%
    Inside Day Range Contraction -4.97%
    Crossed Above 20 DMA Bullish -9.37%
    Bollinger Band Squeeze Range Contraction -9.37%
    Gapped Up Strength -9.37%
    Bollinger Band Squeeze Range Contraction -3.18%
    Older End-of-Day Signals for MNMD ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low 3 minutes ago
    Up 3% 42 minutes ago
    Up 2% about 1 hour ago
    Up 1% about 1 hour ago
    60 Minute Opening Range Breakdown 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    MNMD Chart by TradingView
    Basic chart:

    Profile

    Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Drugs Drug Development Psychoactive Drugs Entheogens Psychedelic Drug N Dimethyltryptamine

    Is MNMD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 18 Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
    May 9 MindMed to Participate at May Investor Conferences
    May 9 New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US
    May 9 Mind Medicine (MindMed) Inc. (MNMD) Q1 2024 Earnings Call Transcript
    May 8 Mind Medicine GAAP EPS of -$1.14 misses by $0.60
    May 8 MindMed Reports First Quarter 2024 Financial Results and Business Updates
    May 7 Mind Medicine Q1 2024 Earnings Preview
    May 6 MindMed releases promising phase 2 data on LSD-related anxiety therapy
    May 4 MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York
    May 2 MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update
    See more MNMD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.22
    52 Week Low 2.41
    Average Volume 1,994,573
    200-Day Moving Average 5.17
    50-Day Moving Average 9.44
    20-Day Moving Average 9.01
    10-Day Moving Average 8.96
    Average True Range 0.72
    RSI (14) 41.52
    ADX 17.82
    +DI 19.35
    -DI 27.24
    Chandelier Exit (Long, 3 ATRs) 8.17
    Chandelier Exit (Short, 3 ATRs) 10.12
    Upper Bollinger Bands 9.98
    Lower Bollinger Band 8.04
    Percent B (%b) 0.09
    BandWidth 21.52
    MACD Line -0.16
    MACD Signal Line -0.04
    MACD Histogram -0.1178
    Fundamentals Value
    Market Cap 329.58 Million
    Num Shares 40.1 Million
    EPS -1.87
    Price-to-Earnings (P/E) Ratio -4.40
    Price-to-Sales 0.00
    Price-to-Book 1.84
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.06
    Resistance 3 (R3) 9.15 8.97 8.92
    Resistance 2 (R2) 8.97 8.75 8.92 8.87
    Resistance 1 (R1) 8.59 8.62 8.50 8.50 8.83
    Pivot Point 8.41 8.41 8.36 8.36 8.41
    Support 1 (S1) 8.03 8.19 7.94 7.94 7.61
    Support 2 (S2) 7.85 8.06 7.80 7.57
    Support 3 (S3) 7.47 7.85 7.52
    Support 4 (S4) 7.38